NCT05007236 Study to Evaluate the Efficacy and Safety of Oral RP7214, a DHODH Inhibitor, in Patients With Symptomatic Mild COVID-19 Infection. Status COMPLETED Phase PHASE2
NCT05004181 Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants Status COMPLETED Phase PHASE2
NCT04987554 Glycophosphopeptical AM3 A Potential Adjuvant in the Treatment of SARS-CoV-2 Status UNKNOWN Phase NA
NCT04955626 To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. Status COMPLETED Phase PHASE3
NCT04949490 A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects Status COMPLETED Phase PHASE2
NCT04941105 Impact of PCSK9 Inhibition on Clinical Outcome in Patients During the Inflammatory Stage of the COVID-19 Status COMPLETED Phase PHASE3
NCT04940182 A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19 Status COMPLETED Phase PHASE3
NCT04937621 Study of Arrhythmia and ECG Abnormalities in Patients With COVID-19 Status COMPLETED Phase N/A
NCT04933981 Benefit of Expanded Surveillance of Nursing Homes During the COVID-19 Pandemic Status COMPLETED Phase N/A
NCT04924660 Novel Experimental COVID-19 Therapies Affecting Host Response Status COMPLETED Phase PHASE2/PHASE3
NCT04922788 Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19 Status COMPLETED Phase PHASE3
NCT04915781 Tobacco Use and COVID-19 Incidence in the Finnish General Population Status COMPLETED Phase N/A
NCT04907890 Long Term Outcomes in COVID-19 Patients Recruited in the CORIST Project Status WITHDRAWN Phase N/A
NCT04903834 Identification of Novel Factors Leading to Activated Macrophage Expansion in COVID19 - INFLAME Study Status UNKNOWN Phase N/A